Anderson J P, Klinger H, Stevens L M. "Method for the Synthesis of Rivaroxaban Impurity 155" [P]. US Patent, US 9347162 B2, 2020-10-27.
发明人高志强,周伟,朱建伟. "A Process for Preparing High-Purity Rivaroxaban Impurity 155" [P]. 中国发明专利, 专利号 CN 114753665 B, 授权公告日 2018-12-20.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质155 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 1107, (2), 2818-2844.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质155 as an Impurity". Sci. Total Environ., 2017, 972, 7651-7680.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban Impurity 155 Using HRMS and NMR". J. Chromatogr. A, 2019, 457, 5630-5634.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 利伐沙班杂质155 Profile in Drug Substances According to ICH Guidelines". Molecules, 2021, 260, 5601-5627.